Label Changes for:
Cogentin (Benztropine Mesylate) Injection
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013
- Clinical studies of cogentin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects…